New Medication Approved to Treat Schizophreniadoi:10.1176/pn.45.23.psychnews_45_23_018Jennifer KellyPsychiatric News
Food and Drug Administration for the treatment of schizophrenia. No dose adjustments are mandatory in patients with mild hepatic impairment because paliperidone ER is not extensively metabolized by the liver.EBSCO_AspBrown University Psychopharmacology Update...
Besides teenage girls, another new group was referred to us: young people from the inpatient psychiatric unit, or the emergency department, of St. Louis Children’s Hospital. The mental health of these kids was deeply concerning—there were diagnoses like schizophrenia, PTSD, bipolar disorder, and...
2021;219(1):368-374. doi:10.1192/bjp.2020.151 PubMedGoogle ScholarCrossref 29. Okusaga OO, Mitchell BG, Bernard JD, Walder A. Clozapine is associated with higher COVID-19 infection rate in veterans with schizophrenia or schizoaffective disorder. J Clin Psychiatry. ...
2 min read · Annalee Armstrong Layoffs 23andMe Cuts Headcount by 40%, Drops Drug Discovery Work November 12, 2024 · 2 min read · Tristan Manalac Schizophrenia AbbVie Shares Plummet 12% as Cerevel Schizophrenia Asset Fails Phase II Trials ...
Cognitive intrusions and reexperiencing are common across a range of disorders including PTSD, OCD, schizophrenia, or even bipolar disorder, this is where having the skills and the correct training would help therapists peel back all the complex layers of a mental disorder. An interesting trauma ...
For the first few decades, ASD was considered extremely rare and was often confused with schizophrenia. Due to a lack of in-depth understanding of ASD, early diagnostic criteria were unclear and treatment was largely limited to behavioral interventions and psychotherapy. Over time, researchers began...
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) report that the U.S. Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application (sNDA) for the treatment of schizophrenia in...
Alzheimer’s disease (AD) stands as the predominant form of dementia, presenting significant and escalating global challenges. Its etiology is intricate and diverse, stemming from a combination of factors such as aging, genetics, and environment. Our cur
Now, we are taking the same approach with long-acting treatments, using advanced science to improve disease outcomes for those living with schizophrenia," said Dr. Hafrun Fridriksdottir, Executive Vice President, Global R&D, at Teva. “We’re pleas...